Abstract
The use of high-capacity adenovirus vectors in cancer therapy has been promising. These vectors are considered safer and with higher cloning capacity in comparison to first and second generations adenovirus vectors. Different approaches can be explored while using adenoviruses as gene carriers, such as inducing the expression of antitumor genes or deleting pro-tumor genes, both leading to…